Erin Lichy teams with Allergan Aesthetics to open up about breast augmentation

Through the partnership, she plans to share her experience—from consultation through recovery—across her social media platforms

GlycoNex wins Japan nod to launch first human trial of lead program in gastrointestinal cancers

The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy

Healync Technologies secures Volrado Venture investment to build next-generation digital hospital infrastructure

Funding to accelerate growth of concierge-style private health services and Aayu’s paperless hospital infrastructure platform

Novo Nordisk and OpenAI forge major AI alliance to accelerate drug discovery & healthcare operations

The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations

FDA clears Travere’s FILSPARI for expanded use in rare kidney disease

FDA grants priority review to Daiichi Sankyo & Merck’s lung cancer drug application

The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck

MSN Laboratories launches SEMABEST, India-made semaglutide pen at nearly 50% lower price

CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing

Regeneron and Telix strike major radiopharma pact in push into next-gen cancer therapies

The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio

FDA presses 2,200+ companies to fix missing clinical trial results

Move amid evidence of widespread reporting gaps

Vir Biotechnology advances VIR-5500 into expansion trials in prostate cancer